SuperworthAcrivon Therapeutics market cap ACRV
Share price times shares outstanding: what the whole company sells for, since 2022.
- Today, Oct 23, 2026
- $74.1M
- Highest close in our data
- $458.6M
- Feb 2023
Acrivon Therapeutics is worth $74.1M at the close on Oct 23, 2026, at $1.73 a share.
That is up 14% over the last year.
Its highest close in our data was $458.6M in Feb 2023.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $74.1M | $47.6M | $94.7M | −4% |
| 2025 | $77M | $32.9M | $206.1M | −58% |
| 2024 | $184.3M | $80.6M | $293.9M | +69% |
| 2023 | $109.2M | $85.2M | $458.6M | −55% |
| 2022 | $240.6M | $240.6M | $250.4M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Acrivon Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| ACRVAcrivon Therapeutics | $74.1M |
| LFVNLifevantage | $73.4M |
| SPROSpero Therapeutics | $64.6M |
| ATNMActinium Pharmaceuticals | $47.8M |
| NATRNatures Sunshine Products | $213.8M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| Peer median | $477.3M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Acrivon Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.